Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 28-Feb 2022. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
4945173013 | Gliclazide and metformin only product in oral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
4945174019 | Product containing only gliclazide and metformin in oral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Gliclazide and metformin only product in oral dose form | Is a | Product containing only gliclazide and metformin (medicinal product) | true | Inferred relationship | Some | ||
Gliclazide and metformin only product in oral dose form | Is a | Gliclazide- and metformin-containing product in oral dose form | true | Inferred relationship | Some | ||
Gliclazide and metformin only product in oral dose form | Has manufactured dose form | Oral dose form | true | Inferred relationship | Some | ||
Gliclazide and metformin only product in oral dose form | Has active ingredient | Metformin (substance) | true | Inferred relationship | Some | 1 | |
Gliclazide and metformin only product in oral dose form | Has active ingredient | Gliclazide (substance) | true | Inferred relationship | Some | 2 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Product containing precisely gliclazide 60 milligram and metformin hydrochloride 500 milligram/1 each prolonged-release oral tablet (clinical drug) | Is a | True | Gliclazide and metformin only product in oral dose form | Inferred relationship | Some |
This concept is not in any reference sets